Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
control group:Conventional treatment
experimental group:Conventional treatment + Reyanning mixture
Sponsors
Jiujiang Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
1 Years to 80 Years
Inclusion criteria
Inclusion criteria: In accordance with the Novel Coronavirus Diagnosis and Treatment Protocol (Trial Version 9) issued by the National Health Commission Diagnosis of mild COVID-19; Signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with normal, severe or critical type of NCOV infection; 2. Other lung diseases; 3. Patients with serious primary diseases such as heart, brain, liver, kidney and hematopoietic system; 4. Patients with basic lung diseases such as severe interstitial lung lesions confirmed by chest CT; 5. People who cannot cooperate in mental state, suffer from mental diseases, cannot control themselves and cannot express themselves clearly; 6. Allergic constitution (such as allergic to two or more drugs or food) or allergic history of this product and conventional treatment drugs; 7. Pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nucleic acid turning negative time;Nucleic acid conversion rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM syndrome scoring Scale;Factors of TCM diagnosis syndrome;Tongue and pulse survey of TCM; | — |
Countries
china
Contacts
Public ContactHongze Wu
Outcome results
None listed